A Randomized, Double-Blind, 3-arm, Parallel Group, Placebo- and Positive-controlled Study to Investigate the Effects of Setmelanotide on QTc Interval in Healthy Subjects
Latest Information Update: 09 May 2024
At a glance
- Drugs Setmelanotide (Primary) ; Moxifloxacin
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Rhythm
- 15 Jun 2022 Status changed from recruiting to completed.
- 22 Sep 2021 New trial record